Long Noncoding RNA E2F4as Promotes Progression and Predicts Patient Prognosis in Human Ovarian Cancer

被引:6
|
作者
Park, Sun-Ae [1 ]
Kim, Lee Kyung [1 ]
Kim, Young Tae [2 ]
Heo, Tae-Hwe [1 ]
Kim, Hee Jung [1 ]
机构
[1] Catholic Univ Korea, Coll Pharm, Integrated Res Inst Pharmaceut Sci, Lab Pharmacoimmunol, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Div Gynecol Oncol,Coll Med, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
ovarian cancer (OC); long noncoding RNAs (lncRNAs); epithelial– mesenchymal transition (EMT); biomarker; MESENCHYMAL TRANSITION; CERVICAL-CANCER; FAMILY; PROLIFERATION; TRANSCRIPTION; RESISTANCE; INVASION; HOTAIR;
D O I
10.3390/cancers12123626
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary LncRNA is a promising biomarker that predicts the prognosis of a variety of cancers, but the important role of E2F4antisense lncRNA in cancer remains unclear. Therefore, we decided to explore the role of E2F4as lncRNA in the blood of an ovarian cancer patient. We found that E2F4as was highly expressed in ovarian cancer patients, and that the higher the expression of E2F4as, the worse the patient's prognosis. In addition, we observed that downregulation of E2F4as in ovarian cancer cells reduced cell proliferation, invasion and migration, decreased expression of EMT-related genes, and increased apoptosis. These findings suggest that E2F4as may be a predictive biomarker in the blood of ovarian cancer patients, and have shown the potential to promote tumor aggression through EMT-related mechanisms. (1) Background: LncRNAs could be a promising biomarker to predict the prognosis of various cancers. The significance of E2F4antisense lncRNA remains unclear in cancer. In this study, we examined the expression level of E2F4as in the serum of ovarian cancer patients and the functional role of E2F4as. (2) Methods: Serum samples were obtained from 108 OC patients and 32 normal patients to measure the expression of E2F4as in the serum. Ovarian cancer cells were used to investigate the role of E2F4as in cell proliferation, invasion, migration and apoptosis, and the expression of E2F4as was knocked down using RNA interference. In addition, E2F4as knockdown cell lines were used in in vivo experiments. (3) Results: The expression of E2F4as was significantly higher in the serum of OC patients than in that of control patients (p < 0.05). The knockdown of E2F4as in ovarian cancer cells led to a decrease in cell proliferation, invasion and migration and an increase in apoptosis. E2F4as knockdown also reduced the expression of epithelium-mesenchymal metastasis (EMT) genes. (4) Conclusion: These findings highlight the clinical significance of E2F4as in predicting the prognosis of OC patients and suggest its potential in promoting tumour aggressiveness by the regulation of EMT-related mechanisms.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [21] Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer
    Qiu, Jun-jun
    Lin, Ying-ying
    Ye, Le-chi
    Ding, Jing-xin
    Feng, Wei-wei
    Jin, Hong-yan
    Zhang, Ying
    Li, Qing
    Hua, Ke-qin
    GYNECOLOGIC ONCOLOGY, 2014, 134 (01) : 121 - 128
  • [22] E2F4 regulatory program predicts patient survival prognosis in breast cancer
    Sari S Khaleel
    Erik H Andrews
    Matthew Ung
    James DiRenzo
    Chao Cheng
    Breast Cancer Research, 16
  • [23] E2F4 regulatory program predicts patient survival prognosis in breast cancer
    Khaleel, Sari S.
    Andrews, Erik H.
    Ung, Matthew
    DiRenzo, James
    Cheng, Chao
    BREAST CANCER RESEARCH, 2014, 16 (06)
  • [24] E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs
    Zhang, Erbao
    Yin, Dandan
    Han, Liang
    He, Xuezhi
    Si, Xinxin
    Chen, Wenming
    Xia, Rui
    Xu, Tongpeng
    Gu, Dongying
    De, Wei
    Guo, Renhua
    Xu, Zhi
    Chen, Jinfei
    ONCOTARGET, 2016, 7 (17) : 23212 - 23226
  • [25] LURAP1L-AS1 long noncoding RNA promotes breast cancer progression and associates with poor prognosis
    Vishnubalaji, Radhakrishnan
    Awata, Dania
    Alajez, Nehad M.
    NON-CODING RNA RESEARCH, 2025, 12 : 1 - 9
  • [26] High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer
    Li, Qiaqia
    Li, Chao
    Chen, Jinbo
    Liu, Peihua
    Cui, Yu
    Zhou, Xinyi
    Li, Huihuang
    Zu, Xiongbing
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 310.e15 - 310.e22
  • [27] Long non-coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer
    Xue, Zhuowei
    Zhu, Xiaolu
    Teng, Yincheng
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5173 - 5181
  • [28] LINC00886, a risk locus-associated long noncoding RNA, promotes ovarian cancer progression.
    Nakamura, Koji
    Reid, Brett M.
    Sellers, Thomas A.
    Karreth, Florian A.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 96 - 97
  • [29] Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer
    Long Huang
    Ling-Min Liao
    An-Wen Liu
    Jian-Bing Wu
    Xiao-Ling Cheng
    Jia-Xin Lin
    Min Zheng
    Archives of Gynecology and Obstetrics, 2014, 290 : 717 - 723
  • [30] Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer
    Huang, Long
    Liao, Ling-Min
    Liu, An-Wen
    Wu, Jian-Bing
    Cheng, Xiao-Ling
    Lin, Jia-Xin
    Zheng, Min
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (04) : 717 - 723